{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:45:26Z","timestamp":1788975926323,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bioadv.2024.213852","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T06:40:31Z","timestamp":1713249631000},"page":"213852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Targeted drug-loaded peptides induce tumor cell apoptosis and immunomodulation to increase antitumor efficacy"],"prefix":"10.1016","volume":"160","author":[{"given":"Hongjie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioadv.2024.213852_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213852_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-022-00394-0","article-title":"IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy","volume":"10","author":"Tang","year":"2022","journal-title":"Biomark. Res."},{"issue":"19","key":"10.1016\/j.bioadv.2024.213852_bb0015","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1200\/JCO.20.00203","article-title":"Irinotecan, temozolomide, and dinutuximab with GM-CSF in children with refractory or relapsed neuroblastoma: a report from the children\u2019s oncology group","volume":"38","author":"Mody","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.bioadv.2024.213852_bb0020","first-page":"22497","article-title":"Replacement of conventional doxorubicin by pegylated liposomal doxorubicin in standard RCHOP chemotherapy for elderly diffuse large B-cell lymphoma: a retrospective study in China","volume":"8","author":"Zhou","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"17","key":"10.1016\/j.bioadv.2024.213852_bb0025","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.bioadv.2024.213852_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1670","article-title":"Recent advances in development of dendritic polymer-based nanomedicines for cancer diagnosis","volume":"13","author":"Li","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.bioadv.2024.213852_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41565-019-0626-4","article-title":"Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo","volume":"15","author":"Zhang","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioadv.2024.213852_bb0040","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fmicb.2015.00628","article-title":"Combinatorial synthesis and screening of cancer cell-specific nanomedicines targeted via phage fusion proteins","volume":"6","author":"Gillespie","year":"2015","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.bioadv.2024.213852_bb0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nano.2010.10.004","article-title":"Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes","volume":"7","author":"Bedi","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2024.213852_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejpb.2022.09.005","article-title":"Self-assembling branched amphiphilic peptides for targeted delivery of small molecule anticancer drugs","volume":"179","author":"Chen","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"9","key":"10.1016\/j.bioadv.2024.213852_bb0055","article-title":"Self-assembly of small organic molecules into Luminophores for Cancer Theranostic applications","volume":"12","author":"Wang","year":"2022","journal-title":"Biosensors (Basel)."},{"key":"10.1016\/j.bioadv.2024.213852_bb0060","doi-asserted-by":"crossref","unstructured":"P.P. Yang, K. Zhang, P.P. He, Y. Fan, X.J. Gao, X. Gao, Z.M. Chen, D.Y. Hou, Y. Li, Y. Yi, D.B. Cheng, J.P. Zhang, L. Shi, X.Z. Zhang, L. Wang, H. Wang, A biomimetic platelet based on assembling peptides initiates artificial coagulation, Sci Adv. 6 (22) (2020) eaaz4107, doi:https:\/\/doi.org\/10.1126\/sciadv.aaz4107.","DOI":"10.1126\/sciadv.aaz4107"},{"issue":"19","key":"10.1016\/j.bioadv.2024.213852_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz4767","article-title":"A biomimetic peptide recognizes and traps bacteria in vivo as human defensin-6","volume":"6","author":"Fan","year":"2020","journal-title":"Sci Adv."},{"issue":"7","key":"10.1016\/j.bioadv.2024.213852_bb0070","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.cclet.2020.03.065","article-title":"Transformable peptide nanoparticles inhibit the migration of N-cadherin overexpressed cancer cells","volume":"31","author":"Fan","year":"2020","journal-title":"Chin. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bioadv.2024.213852_bb0075","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.cclet.2020.04.006","article-title":"In situ construction of ligand nano-network to integrin \u03b1v\u03b23 for angiogenesis inhibition","volume":"31","author":"Chen","year":"2020","journal-title":"Chin. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213852_bb0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/FTD.0000000000000701","article-title":"Cancer chemotherapy: the case for therapeutic drug monitoring","volume":"42","author":"Knezevic","year":"2020","journal-title":"Ther. Drug Monit."},{"issue":"11","key":"10.1016\/j.bioadv.2024.213852_bb0085","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/ijc.27801","article-title":"Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy","volume":"132","author":"Nars","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bioadv.2024.213852_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/btm2.10082","article-title":"Schedule dependent synergy of gemcitabine and doxorubicin: improvement of in vitro efficacy and lack of in vitro-in vivo correlation","volume":"3","author":"Vogus","year":"2018","journal-title":"Bioeng Transl Med."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213852_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1758834010388342","article-title":"Balancing the efficacy and toxicity of chemotherapy in colorectal cancer","volume":"3","author":"Braun","year":"2011","journal-title":"Ther Adv Med Oncol."},{"key":"10.1016\/j.bioadv.2024.213852_bb0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12916-015-0439-8","article-title":"Progress in adjuvant chemotherapy for breast cancer: an overview","volume":"13","author":"Anampa","year":"2015","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213852_bb0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJMe2206661","article-title":"DESTINY-changing results for advanced breast Cancer","volume":"387","author":"Hurvitz","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.bioadv.2024.213852_bb0110","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J. Exp. Med."},{"issue":"14","key":"10.1016\/j.bioadv.2024.213852_bb0115","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1158\/0008-5472.CAN-11-0950","article-title":"Human tumor cells killed by anthracyclines induce a tumor-specific immune response","volume":"71","author":"Fucikova","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioadv.2024.213852_bb0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.canlet.2015.10.002","article-title":"Anthracyclines potentiate anti-tumor immunity: a new opportunity for chemoimmunotherapy","volume":"369","author":"Zhang","year":"2015","journal-title":"Cancer Lett."},{"issue":"979","key":"10.1016\/j.bioadv.2024.213852_bb0125","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/pgmj.2006.055426","article-title":"Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma","volume":"83","author":"Tang","year":"2007","journal-title":"Postgrad. Med. J."},{"issue":"3","key":"10.1016\/j.bioadv.2024.213852_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.lungcan.2014.03.015","article-title":"Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: a literature-based meta-analysis of randomized studies","volume":"84","author":"M\u00f6rth","year":"2014","journal-title":"Lung Cancer"},{"issue":"2009","key":"10.1016\/j.bioadv.2024.213852_bb0135","article-title":"Single agent versus combination chemotherapy for metastatic breast cancer","volume":"2","author":"Carrick","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"issue":"44","key":"10.1016\/j.bioadv.2024.213852_bb0140","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.2174\/1381612829666221124103526","article-title":"Self-assembly of short amphiphilic peptides and their biomedical applications","volume":"28","author":"Le","year":"2022","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.bioadv.2024.213852_bb0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1039\/C3PY00965C","article-title":"Drug release of pH-sensitive poly(L-aspartate)-b-poly(ethylene glycol) micelles with POSS cores","volume":"5","author":"Pu","year":"2014","journal-title":"Polym. Chem."},{"issue":"9","key":"10.1016\/j.bioadv.2024.213852_bb0150","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.bioadv.2024.213852_bb0155","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nnano.2012.45","article-title":"Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner","volume":"7","author":"Chauhan","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.bioadv.2024.213852_bb0160","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nantod.2009.07.001","article-title":"Molecular imaging and therapy of cancer with radiolabeled nanoparticles","volume":"4","author":"Hong","year":"2009","journal-title":"Nano Today"},{"key":"10.1016\/j.bioadv.2024.213852_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.140466","article-title":"Enzyme-induced morphological transformation of self-assembled peptide nanovehicles potentiates intratumoral aggregation and inhibits tumour immunosuppression","volume":"454","author":"Cao","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bioadv.2024.213852_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112389","article-title":"Enzyme-induced morphological transformation of drug carriers: implications for cytotoxicity and the retention time of antitumor agents","volume":"129","author":"Hong","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.bioadv.2024.213852_bb0175","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2019.07.004","article-title":"Enzyme responsive drug delivery systems in cancer treatment","volume":"308","author":"Shahriari","year":"2019","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.bioadv.2024.213852_bb0180","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1039\/C6CS00592F","article-title":"Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment","volume":"46","author":"Dai","year":"2017","journal-title":"Chem. Soc. Rev."},{"issue":"15","key":"10.1016\/j.bioadv.2024.213852_bb0185","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.7150\/thno.87854","article-title":"Stimuli-activatable nanomedicine meets cancer theranostics","volume":"13","author":"Li","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.bioadv.2024.213852_bb0190","article-title":"Reversing chemotherapy resistance by a synergy between lysosomal pH-activated mitochondrial drug delivery and Erlotinib-mediated drug efflux inhibition","author":"Cheng","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"8","key":"10.1016\/j.bioadv.2024.213852_bb0195","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/adhm.201300549","article-title":"Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance","volume":"3","author":"Feng","year":"2014","journal-title":"Adv. Healthc. Mater."},{"issue":"2","key":"10.1016\/j.bioadv.2024.213852_bb0200","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1021\/acs.accounts.8b00398","article-title":"Bispyrene-based self-assembled nanomaterials: in vivo self-assembly, transformation, and biomedical effects","volume":"52","author":"He","year":"2019","journal-title":"Acc Chem Res."},{"issue":"5","key":"10.1016\/j.bioadv.2024.213852_bb0205","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1208\/s12249-014-0208-6","article-title":"Targeted gene delivery to MCF-7 cells using peptide-conjugated Polyethylenimine","volume":"16","author":"Mokhtarzadeh","year":"2015","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.bioadv.2024.213852_bb0210","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1021\/acsmaterialslett.2c01093","article-title":"Matrix metalloproteinase-2-induced morphologic transformation of self- assembled peptide nanocarriers inhibits tumor growth and metastasis","volume":"5","author":"Cao","year":"2023","journal-title":"Acs Materials Lett."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213852_bb0215","doi-asserted-by":"crossref","first-page":"19350","DOI":"10.1038\/s41598-021-98638-w","article-title":"Effects of hypoxia and nanocarrier size on pH-responsive nano-delivery system to solid tumors","volume":"11","author":"Soltani","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2024.213852_bb0220","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1021\/acsmaterialslett.3c00357","article-title":"Stepwise targeting and tandem responsive peptide nanoparticles enhance immunotherapy through prolonged drug retention","author":"Cao","year":"2023","journal-title":"ACS Materials Lett."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213852_bb0225","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/acsami.3c13855","article-title":"Enzyme-induced shape-shifting peptide nanocarrier coloaded with paclitaxel and dipyridamole inhibits platelet function and tumor metastasis","volume":"16","author":"F. Meng, X. Zhai, J. Ma, A. Li, X. Wang, J. Bai","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioadv.2024.213852_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-015-0156-7","article-title":"Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles","volume":"14","author":"Sulheim","year":"2016","journal-title":"J Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213852_bb0235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nnano.2016.160","article-title":"Pair correlation microscopy reveals the role of nanoparticle shape in intracellular transport and site of drug release","volume":"12","author":"Hinde","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.bioadv.2024.213852_bb0240","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/anie.201710237","article-title":"Tandem molecular self-assembly in liver Cancer cells","volume":"57","author":"Zhan","year":"2018","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"4","key":"10.1016\/j.bioadv.2024.213852_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/biom8040163","article-title":"Triptolide decreases cell proliferation and induces cell death in triple negative MDA-MB-231 breast cancer cells","volume":"8","author":"Varghese","year":"2018","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.bioadv.2024.213852_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22928","article-title":"Synergistic effect of anethole and doxorubicin alleviates cell proliferation, cell cycle arrest, and ER stress and promotes ROS-mediated apoptosis in triple-negative breast cancer cells","volume":"35","author":"Arumugam","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"6","key":"10.1016\/j.bioadv.2024.213852_bb0255","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/jphp.12539","article-title":"Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism","volume":"68","author":"Meredith","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioadv.2024.213852_bb0260","doi-asserted-by":"crossref","first-page":"116405","DOI":"10.1016\/j.taap.2023.116405","article-title":"Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: anticancer efficacy and safety","volume":"461","author":"Elfadadny","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioadv.2024.213852_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021222","article-title":"Predicting modifiers of genotype-phenotype correlations in craniofacial development","volume":"24","author":"Kar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bioadv.2024.213852_bb0270","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J. Cell. Physiol."},{"issue":"10286","key":"10.1016\/j.bioadv.2024.213852_bb0275","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"issue":"28","key":"10.1016\/j.bioadv.2024.213852_bb0280","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1200\/JCO.2005.07.501","article-title":"Proliferation marker Ki-67 in early breast cancer","volume":"23","author":"Urruticoechea","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213852_bb0285","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.apsb.2021.05.016","article-title":"Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy","volume":"12","author":"Ma","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioadv.2024.213852_bb0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.oraloncology.2019.06.016","article-title":"Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer","volume":"95","author":"Park","year":"2019","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bioadv.2024.213852_bb0295","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fimmu.2017.00194","article-title":"CD4 CTL, a cytotoxic subset of CD4(+) T cells, their differentiation and function","volume":"8","author":"Takeuchi","year":"2017","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.bioadv.2024.213852_bb0300","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1021\/nn3059295","article-title":"Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge","volume":"7","author":"H\u00fchn","year":"2013","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.bioadv.2024.213852_bb0305","article-title":"Hematological effects of gold nanorods on erythrocytes: hemolysis and hemoglobin conformational and functional changes","volume":"4","author":"Zhao","year":"2017","journal-title":"Adv Sci (Weinh)."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213852_bb0310","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12951-020-00747-7","article-title":"Density of surface charge is a more predictive factor of the toxicity of cationic carbon nanoparticles than zeta potential","volume":"19","author":"Weiss","year":"2021","journal-title":"J Nanobiotechnol."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950824000955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950824000955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T18:00:39Z","timestamp":1738519239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950824000955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":62,"alternative-id":["S2772950824000955"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2024.213852","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted drug-loaded peptides induce tumor cell apoptosis and immunomodulation to increase antitumor efficacy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2024.213852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"213852"}}